Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,701 USD | -0,74% | -8,19% | -76,08% |
Omzet 2024 * | 4,6 mln. 4,33 mln. | Omzet 2025 * | 1,3 mln. 1,22 mln. | Marktkapitalisatie | 28,85 mln. 27,1 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -49 mln. -46,03 mln. | Nettowinst (verlies) 2025 * | -60 mln. -56,37 mln. | EV/omzet 2024 * | -3,31 x |
Nettoliquiditeiten 2024 * | 44,1 mln. 41,43 mln. | Nettoliquiditeiten 2025 * | 89,5 mln. 84,08 mln. | EV/omzet 2025 * | -46,7 x |
K/w-verhouding 2024 * |
-0,6
x | K/w-verhouding 2025 * |
-0,7
x | Werknemers | 29 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 88,37% |
Recentste transcriptie over Spruce Biosciences, Inc.
1 dag | -0,74% | ||
1 week | -8,19% | ||
Lopende maand | -10,80% | ||
1 maand | -7,64% | ||
3 maanden | -70,79% | ||
6 maanden | -49,02% | ||
Lopend jaar | -76,08% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 54 | 03-01-22 | |
Samir Gharib
DFI | Director of Finance/CFO | 41 | 01-05-20 |
Michael Grey
CHM | Chairman | 71 | 01-04-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Dan Spiegelman
BRD | Director/Board Member | 65 | 09-09-20 |
Michael Grey
CHM | Chairman | 71 | 01-04-17 |
Tiba Aynechi
BRD | Director/Board Member | 48 | 01-05-16 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
18-04-24 | 0,701 | -0,74% | 311 619 |
17-04-24 | 0,7062 | +0,86% | 707 703 |
16-04-24 | 0,7002 | -0,78% | 861 965 |
15-04-24 | 0,7057 | -4,14% | 1 277 676 |
12-04-24 | 0,7362 | -3,58% | 521 794 |
uitgestelde koers Nasdaq, 18 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-76,08% | 28,85 mln. | |
-1,82% | 41,35 mld. | |
+41,82% | 40,38 mld. | |
+2,56% | 39,05 mld. | |
-12,11% | 26,67 mld. | |
+3,09% | 24,07 mld. | |
-24,16% | 18,36 mld. | |
+22,12% | 11,6 mld. | |
-3,74% | 11,68 mld. | |
+7,75% | 11,15 mld. |